Trial
NCT00041470
Navelbine, Taxol, Herceptin and Neupogen in Stage IV Breast Cancer: A Phase I - II Trial
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Washington
Collaborators
Amgen; Bristol-Myers Squibb; GlaxoSmithKline
Condition
Breast Cancer
Intervention
Paclitaxel
Why stopped
Sponsor withdrew the study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-07-17